Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis.

about

Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis.

Item

http://www.wikidata.org/entity/Q47975335

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Long-Term Safety and Efficacy ...... idney Disease Not on Dialysis.

@en

Long-Term Safety and Efficacy ...... idney Disease Not on Dialysis.

@nl

type

Item

label

Long-Term Safety and Efficacy ...... idney Disease Not on Dialysis.

@en

Long-Term Safety and Efficacy ...... idney Disease Not on Dialysis.

@nl

prefLabel

Long-Term Safety and Efficacy ...... idney Disease Not on Dialysis.

@en

Long-Term Safety and Efficacy ...... idney Disease Not on Dialysis.

@nl

P1476

Long-Term Safety and Efficacy ...... Kidney Disease Not on Dialysis

@en

P2093

Chisato Kameoka

http://www.w3.org/2001/XMLSchema#string

Kentarou Kuroishi

http://www.w3.org/2001/XMLSchema#string

Tadao Akizawa

http://www.w3.org/2001/XMLSchema#string

Yusuke Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Oral phosphate binders in patients with kidney failure

Comparison of concurrent complications of CKD by 2 risk categorization systems.

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Next-generation phosphate binders: focus on iron-based binders.

Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial.

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.

Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients.

Serum phosphate levels and mortality risk among people with chronic kidney disease.

Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate.

Progressive accumulation of lanthanum in the liver of normal and uremic rats.

P304

173-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1744-9987.12502

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Junko Tsukada

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28194884

http://www.w3.org/2001/XMLSchema#string